Black Friday Get Elite for just $149.00 Claim Now

Top Analyst Reports for Berkshire Hathaway, JPMorgan & Procter & Gamble

By Mark Vickery | November 19, 2026, 3:23 PM

Thursday, November 19, 2026

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), JPMorgan Chase & Co. (JPM) and The Procter & Gamble Co. (PG), as well as a micro-cap stock National Presto Industries, Inc. (NPK). The Zacks microcap research is unique as our research content on these small and under-the-radar companies is the only research of its type in the country.

These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

You can see all of today’s research reports here >>>

Ahead of Wall Street

The daily 'Ahead of Wall Street' article is a must-read for all investors who would like to be ready for that day's trading action. The article comes out before the market opens, attempting to make sense of that morning's economic releases and how they will affect that day's market action. You can read this article for free on our home page and can actually sign up there to get an email notification as this article comes out each morning.

You can read today's AWS here >>> ANT Marks Momentous Occasion for Wall Street

Today's Featured Research Reports

Berkshire Hathaway’s shares have outperformed the Zacks Insurance - Property and Casualty industry over the past year (+13.6% vs. +12.5%). The company benefits from diversified businesses, disciplined underwriting and ample liquidity that support durable earnings and flexible capital allocation. Insurance float remains a low-cost funding source, while manufacturing, BNSF and Berkshire Hathaway Energy broaden earnings. 

Acquisitions and renewed repurchases offer additional avenues for deploying capital. However, rising auto claim costs have weakened GEICO underwriting, while catastrophe exposure remains. Lower short-term rates continue to reduce insurance investment income. Railroad and utility operations demand heavy capital spending, despite recent earnings growth. 

Greg Abel's leadership also leaves longer-term capital allocation execution to be tested. These competing factors support a balanced risk-reward profile and a Neutral recommendation.

(You can read the full research report on Berkshire Hathaway here >>>)

Shares of JPMorgan have outperformed the Zacks Financial - Investment Bank industry over the past year (+12.1% vs. +8%). The company’s share price reflects investors' confidence in its diversified franchise and extensive deposit base, which support its earnings resilience. Loan growth and an asset-sensitive balance sheet are expected to drive net interest income (NII), while investment banking (IB) and asset management inflows enhance fee opportunities. 

Branch expansion and digital investment will likely deepen customer relationships, while a strong liquidity profile drives enhanced capital distributions, with room for selective investments. 

However, uncertain market activity and subdued mortgage demand are likely to limit overall growth. Expenses are likely to remain high as it invests in technology, marketing and growth initiatives. Credit quality is a watch item in a tougher, uncertain macroeconomic backdrop.

(You can read the full research report on JPMorgan here >>>)

Procter & Gamble’s shares have outperformed the Zacks Consumer Products - Staples industry over the past year (+16.3% vs. +16.1%). The company’s growth prospects remain encouraging, supported by broad-based organic sales momentum, product innovation and improving consumer demand. Strength across Fabric and Home Care and Beauty, driven by brands like Tide, Gain and Pantene, is reinforcing market positioning and revenue growth. 

Procter & Gamble’s focus on premiumization, consumer engagement and category expansion is creating additional growth opportunities. Productivity initiatives, supply-chain automation and disciplined cost management are strengthening operational efficiency and supporting profitability. 

However, PG faces rising commodity, energy and transportation costs that could pressure margins. Weak volumes in Health Care and Grooming, intense competition and market-share losses in certain categories further challenge revenue growth.

(You can read the full research report on Procter & Gamble here >>>)

Shares of National Presto Industries have outperformed the Zacks Diversified Operations industry over the past year (+55.9% vs. -6.5%). This microcap company with a market capitalization of $1.03 billion has an outlook supported by a $1.94 billion Defense backlog, providing multi-year revenue visibility, while recent contract awards extend deliveries into 2030. Higher Defense shipments, favorable product mix and operating efficiencies are strengthening profitability. 

Improved operating cash flow, reduced borrowings and integrated manufacturing capabilities further support expansion opportunities. The company’s planned medium-caliber ammunition facility could broaden its participation in next-generation defense programs, while favorable U.S. defense spending trends offer additional growth opportunities. 

However, Housewares faces weak demand and tariff uncertainty, while its recent profitability benefited substantially from refunds that may not recur. Persistent Safety losses, rising work-in-process inventory and exposure to fixed-price Defense contracts also pose execution and margin risks. 

(You can read the full research report on National Presto Industries here >>>)

Other noteworthy reports we are featuring today include GSK plc (GSK), Republic Services, Inc. (RSG) and Nokia Oyj (NOK).

Mark Vickery
Senior Editor

Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>

Today's Must Read

Solid Insurance Business Aid Berkshire (BRK.B), Cat Loss Ail

Expansion Moves, Higher Rates, Solid IB Aids JPMorgan (JPM), Costs Ail

Procter & Gamble (PG) Gains Cost Efficiency With Supply Chain Upgrades

Featured Reports

GSK's Specialty Medicines Growth Offsets GenMed Weakness
Per the Zacks analyst, GSK's Specialty Medicines unit benefits from strong HIV, respiratory and oncology sales, while pricing and generic pressures weigh on GenMed revenues.

Pricing Power Aids Republic Services (RSG) Amid Volume Weakness
Per the Zacks analyst, Republic Services' prudent pricing and strong customer retention support organic growth. However, persistent volume weakness could affect operating leverage.

Nokia (NOK) Rides on Strength in 5G and AI Networking Vertical
Per the Zacks analyst, 5G network upgrades and strength in Network Infrastructure segment backed by growing AI networking demand will likely drive Nokia's top line.

Robust Mask Sales Aid ResMed (RMD) Amid Competitive Pressure
The Zacks analyst is impressed with ResMed's strong Mask sales growth globally. Yet, stiff competition remains a concern.

West Pharmaceutical (WST) Gains From HVP Demand Amid SmartDose Exit
Per the Zacks analyst, West Pharmaceutical benefits from HVP demand, GLP-1 exposure and margin gains, while West Vantage transition, lost SmartDose revenues and working-capital needs constrain growth.

Permian Resources (PR) To Benefit from Strong Delaware Position
The Zacks analyst notes that Permian Resources' large position in the core Delaware Basin, controlling about 560,000 net acres post 2026 acquisitions, gives it a long runway for future drilling.

AI Cloud Growth Aids IREN (IREN), but Execution and Funding Risks Loom
Per the Zacks analyst, IREN benefits from growing AI cloud demand, contracted revenues and expanding capacity. However, delivery delays, rising costs and heavy funding needs limit earnings visibility.

New Upgrades

RenaissanceRe (RNR) Rides on Fee Income Growth, Strategic Acquisitions
Per the Zacks analyst, RenaissanceRe benefits from fee income growth, strategic acquisitions and higher reinvestment yields, supporting earnings and book-value growth.

Victoria's Secret (VSXY) Gains Momentum on Brand Revitalization
Per the Zacks analyst, Victoria's Secret benefits from brand momentum, stronger full-price sales, margin expansion and growth opportunities across PINK, Beauty and international markets.

Dropbox (DBX) Rides on AI Innovation and Expanding Growth Prospects
Per the Zacks analyst, Dropbox benefits from growing user engagement, AI-powered innovations, expanding integrations and disciplined cost management.

New Downgrades

Supply-Chain Constraints and Production Challenges Ail Boeing (BA)
Per the Zacks analyst, supplier-readiness issues involving engines and aircraft components constrain Boeing's production ramp-up, potentially delaying deliveries, raising costs and limiting margin.

CC Faces Weak Demand, Mounting Liabilities and Financial Strain
Per the Zacks analyst, Chemours faces persistent TiO2 weakness, mounting legal and environmental liabilities, high debt and declining capital returns, clouding its earnings recovery prospects.

Soft Traffic And High Costs Hurt Red Robin's (RRGB) Prospects
Per the Zacks analyst, Red Robin is contending with negative guest traffic, elevated general liability expenses, and an uncertain macro environment. Also, a rise in marketing spend poses concern.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
JPMorgan Chase & Co. (JPM): Free Stock Analysis Report
 
Procter & Gamble Company (The) (PG): Free Stock Analysis Report
 
Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report
 
National Presto Industries, Inc. (NPK): Free Stock Analysis Report
 
GSK PLC Sponsored ADR (GSK): Free Stock Analysis Report
 
Nokia Corporation (NOK): Free Stock Analysis Report
 
Republic Services, Inc. (RSG): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News